Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Outcomes Comparison of Robotic, Retropubic, and Perineal Prostatectomy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT00442000
First received: February 28, 2007
Last updated: March 19, 2012
Last verified: March 2012
  Purpose

Compare peri-operative and postoperative outcomes of the three different surgical approaches to prostatectomy


Condition Intervention
Prostate Cancer
Procedure: Prostatectomy

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Outcomes Comparison of Robotic, Retropubic, and Perineal Prostatectomy

Resource links provided by NLM:


Further study details as provided by William Beaumont Hospitals:

Enrollment: 700
Study Start Date: January 2005
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Prostatectomy
    Patients undergoing prostatectomy.
    Other Name: prostatectomy
Detailed Description:

Existing data collected from Prostatectomy Database study and Urology Database study will be analyzed. Compare peri-operative and postoperative outcomes of the three different surgical approaches to prostatectomy

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients undergoing prostatectomy at William Beaumont-Royal Oak.

Criteria

Inclusion Criteria:

  • 18 years of age
  • Radical Prostatectomy at William Beaumont Hospital

Exclusion Criteria:

  • Dementia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00442000

Locations
United States, Michigan
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073
Sponsors and Collaborators
William Beaumont Hospitals
Investigators
Principal Investigator: Kevin Feber, M.D. William Beaumont Hospitals
  More Information

No publications provided

Responsible Party: William Beaumont Hospitals
ClinicalTrials.gov Identifier: NCT00442000     History of Changes
Other Study ID Numbers: E2007-024
Study First Received: February 28, 2007
Last Updated: March 19, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by William Beaumont Hospitals:
Prostate Cancer
Prostatectomy

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms

ClinicalTrials.gov processed this record on November 25, 2014